IP Library Granted Patent US 8,721,519
Granted Patent B2
US 8,721,519 · App. 11/448,252 · Granted May 13, 2014

Implantable mesh combining biodegradable and non-biodegradable fibers

Inventors: Min-Shyan Sheu (Chelmsford, MA); Jianmin Li (Lexington, MA)
Assignee: Boston Scientific Scimed, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,721,519
App. No.
11/448,252
Granted
May 13, 2014
Kind
B2
Abstract

Disclosed are mesh materials adapted for use in an implantable sling. The mesh materials include biodegradable and non-degradable components that may be adapted to facilitate scar-tissue in-growth as the biodegradable components degrade.

Claims (27)

1. A mesh for use in an implantable sling comprising:

a plurality of non-biodegradable transverse strands; and

a plurality of non-biodegradable longitudinal strands, the plurality of non-biodegradable transverse strands and the plurality of non-biodegradable longitudinal strands being arranged in a uniform grid,

wherein:

a plurality of biodegradable fibers are woven through the uniform grid, the plurality of biodegradable fibers being arranged in a same direction as the plurality of non-biodegradable longitudinal strands, and

the plurality of biodegradable fibers being of varying length, a longest biodegradable fiber of the plurality of biodegradable fibers having a length that is shorter than a longitudinal length of the uniform grid.

2. The mesh of claim 1 , wherein at least one of the plurality of non-biodegradable longitudinal strands and the plurality of non-biodegradable transverse strands includes an exterior biodegradable shell.

3. The mesh of claim 1 , wherein at least one of the plurality of biodegradable fibers includes a material that degrades in-vivo at a rate that facilitates a predetermined rate of scar tissue in-growth into the mesh.

4. The mesh of claim 1 , wherein a ratio of biodegradable fibers to non-degradable longitudinal strands is greater than about 1/4 and less than about 3/1.

5. The mesh of claim 1 , further comprising a therapeutic-agent.

6. The mesh of claim 1 , wherein, upon degradation of at least one biodegradable fiber of the plurality of biodegradable fibers, a gap of greater than about 50 μm forms in the mesh between a first transverse non-biodegradable strand of the plurality of transverse non-biodegradable strands and a second transverse non-biodegradable strand of the plurality of transverse non-biodegradable strands, the first transverse non-biodegradable strand being adjacent to the second non-biodegradable strand in the uniform grid.

7. The mesh of claim 1 , wherein at least one non-biodegradable transverse strand of the plurality of non-biodegradable transverse strands is attached to two or more of the plurality of non-biodegradable longitudinal strands by an adhesive.

8. The mesh of claim 1 , wherein the uniform grid is adapted to extend across a patient's urethra.

9. The mesh of claim 1 , wherein a ratio of biodegradable fibers to non-degradable longitudinal strands is more than 1/4 and less than 2/1.

10. A mesh for use in an implantable sling comprising:

a plurality of non-biodegradable transverse strands;

a plurality of non-biodegradable longitudinal strands, the plurality of non-biodegradable transverse strands and the plurality of non-biodegradable longitudinal strands being arranged in a grid; and

a plurality of biodegradable longitudinal segments, each biodegradable longitudinal segment of the plurality of biodegradable longitudinal segments connecting only a respective first non-biodegradable transverse strand of the plurality of non-biodegradable transverse strands and a respective second non-biodegradable transverse strand of the plurality of non-biodegradable transverse strands that is adjacent to the respective first non-biodegradable transverse strand in the grid.

11. The mesh of claim 10 , wherein at least one of the plurality of non-biodegradable longitudinal strands and the plurality of non-biodegradable transverse strands includes an exterior biodegradable shell.

12. The mesh of claim 10 , wherein the plurality of biodegradable longitudinal segments are attached to the grid using an adhesive.

13. The mesh of claim 10 , wherein the plurality of biodegradable longitudinal segments are laser welded to the grid.

14. The mesh of claim 10 , wherein the plurality of biodegradable longitudinal segments are formed by patterned air-drying of a solvent including a biodegradable polymer.

15. The mesh of claim 10 , wherein at least one of the plurality of biodegradable longitudinal segments includes a material that degrades in-vivo at a rate that facilitates a predetermined rate of scar tissue in-growth into the mesh.

16. The mesh of claim 10 , wherein at least one of the plurality of biodegradable longitudinal segments includes a therapeutic-agent.

17. The mesh of claim 10 , wherein the grid is adapted to extend across a patient's urethra.

18. The mesh of claim 10 , wherein the grid is non-uniform.

19. The mesh of claim 10 , wherein any three sequential non-biodegradable transverse strands of the plurality of non-biodegradable transverse strands in the grid have, at most, two of the three sequential non-biodegradable transverse strands connected by one or more biodegradable longitudinal segments of the plurality of biodegradable longitudinal segments.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2006
From: SHEU, MIN-SHYAN; LI, JIANMIN
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 017965/0584 →
Continuity (1)
Related Publication 20070282160A1 · Dec 6, 2007